Sign up to save your podcasts
Or
Share The HEART-FID Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The HEART-FID Trial
Robert Mentz and C. Michael Gibson discuss the latest trial to address whether iron supplementation, this time with ferric carboxymaltose, improves outcomes for patients with HF and iron deficiency.
View all episodes
By TCTMD
4
22 ratings
Robert Mentz and C. Michael Gibson discuss the latest trial to address whether iron supplementation, this time with ferric carboxymaltose, improves outcomes for patients with HF and iron deficiency.
More shows like Talking Points
View all
JAMA Editors' Summary
127 Listeners
Planet Money
30,866 Listeners
EMCrit FOAM Feed
1,856 Listeners
NEJM This Week
314 Listeners
JACC Podcast
160 Listeners
This Week in Cardiology
854 Listeners
JAMA Clinical Reviews
478 Listeners
Heart Sounds Podcast
12 Listeners
Circulation on the Run
31 Listeners
Mayo Clinic Talks
283 Listeners
The Curbsiders Internal Medicine Podcast
3,324 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
134 Listeners
Core IM | Internal Medicine Podcast
1,085 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
50 Listeners
Cardionerds: A Cardiology Podcast
413 Listeners